30% less pain
according to Buisman et al.
2020 saw a randomised controlled trial involving 95 patients, the objective of which was to study pain in women undergoing oocyte retrieval with a reduced needle (20/17 G) compared to a standard needle (16 G)4. It concluded that the use of a thinner needle results in significantly lower (and clinically relevant) pain scores during oocyte retrieval.
Using single Sense, patients experienced 30% less pain, compared to the group using a standard needle. Patients in the reduced needle group requested significantly less analgesia during oocyte retrieval than patients in the standard needle group. Pain scores remained significantly lower up to until 2 days after the procedure.